DR   CCRID; 4201PAT-CCTCC00204
DR   Wikidata; Q94103497
RX   Patent=CN101016536A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200635.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a wild-type hepatitis B virus (HBV) genome.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from sampling site: Liver.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 23-09-21; Version: 7
RX   Patent=CN101016536A;
RA   Lin X., Huang Q.-L., Bai S.-Y., Lin J.-Y.;
RT   "Construction of B-type hepatitis virus cell strain HepG2-RHBV.";
RL   Patent number CN101016536A, 15-Aug-2007.